Brand unveiling: While debuting its new brand at SLAS for the first time, Revvity presents its continued commitment to expanding the boundaries of human potential through science. The transformed ...

WALTHAM, Mass. & SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. and Element Biosciences, Inc., a developer of the AVITI™ System, an innovative and emerging genomic sequencing platform, today announced a ...

Revvity emerged from the life sciences and diagnostics business of PerkinElmer (MA, USA) in May 2023 when the company divested its food, applied and enterprise services businesses. These businesses ...

Dipti Mehta has worked as a Senior Application Scientist at Revvity since 2022. Her research in DNA and protein assay development with LabChip GX Touch technology has generated new commercial assays.

Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...

Revvity exceeded EPS and revenue expectations for Q4 2025. Stock price fell 7.89% in pre-market trading despite earnings beat. Company launched new AI services and acquired ACD/Labs. Operating margins ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. is set to boldly unveil its new branding while showcasing more than 40 products from its life sciences and diagnostics portfolio at SLAS2024 to be held ...